SYSTEMATIC REVIEW article

Front. Allergy, 01 September 2025

Sec. Food Allergy

Volume 6 - 2025 | https://doi.org/10.3389/falgy.2025.1635274

Prevalence of shrimp allergy: a meta-analysis based on different diagnostic methods

  • 1. Clinical Laboratory of the Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People’s Hospital, Lishui, Zhejiang, China

  • 2. Nursing Department of the Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People’s Hospital, Lishui, Zhejiang, China

Abstract

Background:

Shrimp allergy (SA) represents a significant public health concern, yet its overall prevalence remains unclear.

Method:

A systematic search of PubMed, Web of Science, and Embase through September 30, 2024 identified 40 studies that reported SA prevalence using self-reported symptoms, physician diagnosis, skin prick tests, specific IgE, or food challenge tests.

Results:

The pooled prevalence was estimated at 1.90% for self-reported symptomatic SA and 1.94% for self-reported physician-diagnosed SA, while testing via skin prick or specific IgE yielded a prevalence of 2.76%. Notably, symptomatic testing showed a lower prevalence of 0.43%, and food challenge tests confirmed a prevalence of 0.50%. Considerable heterogeneity was observed across studies, with prevalence varying by region and age group, and no publication bias was detected.

Conclusion:

These findings indicate that the prevalence of SA varies with diagnostic criteria, age, and region, underscoring the need for harmonized diagnostic standards to improve prevalence estimates and guide public health strategies.

Systematic Review Registration:

identifier [CRD420251003956].

1 Introduction

In recent years, food allergies have emerged as a growing global public health concern, with both prevalence and associated burden increasing steadily (). Among various food allergies, shellfish allergy—particularly SA—deserves special attention, given the widespread consumption and affordability of shrimp.

Despite heightened awareness of SA, the pooled prevalence from large-scale studies remains unclear due to variations in study design and diagnostic criteria. These discrepancies largely arise from differences in self-reporting, skin prick tests (SPT), specific IgE (sIgE) measurements, and oral food challenge tests. Methodological inconsistencies across studies have led to substantial variability in prevalence estimates (). Furthermore, demographic factors such as age and geographic location may influence the prevalence of SA; however, systematic assessments of these factors are currently limited ().

To address these gaps, a comprehensive meta-analysis is necessary to synthesize existing epidemiological data and provide a more accurate estimate of SA prevalence. The findings of this analysis will offer updated evidence to inform clinical practice and guide public health strategies.

2 Methods

2.1 Study design and registration

This meta-analysis adhered to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The study protocol was registered in the PROSPERO database (Registration No.: CRD420251003956).

2.2 Search strategy

A comprehensive literature search was conducted in PubMed, Web of Science, and Embase from their inception until September 30, 2024. Considering that in some regions “Shrimp” and “Prawn” are used interchangeably while in others they refer to distinct species, both terms were included. The search combined allergy-related terms (“Allergy”, “Hypersensitivity”, “Anaphylaxis”) with prevalence-related terms (“Prevalence”, “Incidence”, “Epidemiology”, “Risk factors”) using Boolean operators. The search was limited to studies on humans published in English.

In addition to the articles retrieved from the above databases, we also included studies mentioned in the reference lists of relevant articles. These studies were identified from known review articles and reference lists. To ensure the quality and scientific validity of the included studies, we primarily relied on research published in peer-reviewed journals. Therefore, we decided not to include gray literature in this study.

2.3 Inclusion and exclusion criteria

Two independent reviewers (Jiaqi Chen and Qiang Zhang) screened the retrieved studies according to predefined criteria, with disagreements resolved through discussion or consultation with a third reviewer (Yongli Ying). The inclusion criteria were as follows: 1. Study Design: Cross-sectional, cohort, or case-control studies. 2. Population: Individuals of all ages with reported SA prevalence. 3. Outcomes: Prevalence data based on one or more of the following: Self-reported symptoms, Physician diagnosis, Skin prick test (SPT), Serum specific IgE (sIgE), Food challenge tests. The exclusion criteria were: 1. Review articles, case reports, conference abstracts, and editorials. 2. Studies lacking relevant prevalence data. 3. Studies using duplicate datasets (only the most comprehensive data was included). 4. Studies that do not meet the definitions or criteria for skin prick test (SPT) or serum specific IgE (sIgE) diagnosis.

2.4 Definition of SA

In this study, we adopted a comprehensive approach to identifying SA without distinguishing between IgE-mediated and non-IgE-mediated reactions or differentiating between food allergies and food intolerances. SA was defined based on the following criteria: 1. self-reported symptomatic SA: Individuals experiencing allergic symptoms after shrimp consumption. Referring to an individual experiencing allergic symptoms after shrimp consumption. 2. Self-reported physician-diagnosed SA: SA diagnosed by a physician as reported by the individual. 3. SPT- or sIgE-based SA: Elevated specific IgE levels (≥0.35 kU/L) or a positive skin prick test (SPT) result (wheal ≥ 3 mm larger than the control). 4. SPT- or sIgE-based symptomatic SA: Positive SPT or sIgE results accompanied by allergic symptoms. and 5. Food challenge-confirmed SA: SA established through open, single-blind, or double-blind placebo-controlled food challenge tests.

2.5 Data extraction and quality assessment

Two independent reviewers (Jiaqi Chen and Xuying Zhang) extracted data using a pre-designed data extraction form, including study characteristics (first author, publication year, country, study design, sample size, and age group) and outcome measures (prevalence rates and diagnostic methods).

Quality assessment was performed using different appraisal tools based on study design. For cross-sectional studies, the Joanna Briggs Institute (JBI) Critical Appraisal Checklist was used, with studies scoring ≥6 considered high quality, 4–5 as moderate quality, and ≤3 as low quality. For cohort studies, the Newcastle-Ottawa Scale (NOS) was applied, with studies scoring ≥7 classified as high quality, 4–6 as moderate quality, and ≤3 as low quality. Disagreements between reviewers were resolved through discussion.

2.6 Statistical analysis

Meta-analysis was conducted using Comprehensive Meta-Analysis (CMA) software. Heterogeneity was assessed using Cochran's Q test and the I² statistic, with I² > 50% indicating substantial heterogeneity. Random-effects models were applied to pool the prevalence of SA in the presence of high heterogeneity, while fixed-effects models were used for studies with low heterogeneity (I² < 50% and P > 0.05). Publication bias was evaluated using Egger's regression test () and Funnel plot. A P-value of <0.05 was considered statistically significant for all tests.

For prevalence estimates, we did not differentiate between lifetime and point prevalence. If a study reported both, we used lifetime prevalence for analysis. We prioritized extracting raw data from studies whenever possible; if raw data were unavailable, weighted data were used instead. To estimate the true prevalence of SA, we adjusted for participant dropout in some studies based on the proportion of individuals who completed the study. If a study reported both shrimp and prawn allergy prevalence, we included the data with the larger sample size.

To analyze age-based differences, we categorized study participants as children (<18 years old) or adults (≥18 years old). For studies that included both age groups, classification was based on the predominant age distribution within the study.

3 Results

3.1 Study selection and characteristics

A total of 823 articles were identified through the search process, of which 40 studies were ultimately included in the systematic review. The detailed selection process is shown in Figure 1. Among these studies, 36 adopted a cross-sectional design, while 4 employed a cohort design. Regarding study populations, 23 studies focused on children, 12 on adults, and 5 included multiple age groups. The quality assessment revealed that 9 studies were of high quality, 17 were of moderate quality, and 14 were of low quality (Table 1).

Figure 1

Table 1

AuthorYearCountryRegionStudy designPopulationDiagnosisPrevalence (%)Sample numberStudy quality
Beltrán-Cárdenas CE ()2021ColombiaAmericaCross- sectional studyChildrenSR-SA1.34969Low
Lyons SA ()2019MixedEuropeCross- sectional studyAdultSR-SA3.5017,295High
SPT/sIgE-S-SA0.4223,405
Cabrera-Chávez F ()2018ElSalvadorAmericaCross- sectional studyChildrenSR-SA1.18508Moderate
Ju SY ()2015KoreaAsiaCross- sectional studyAdult-majoritySR-SA1.84543Low
PD-SA1.66543
Li J ()2020ChinaAsiaCross- sectional studyChildrenSPT/sIgE-SA2.6416,875Moderate
Ma Z ()2021ChinaAsiaCross- sectional studyChildrenSPT/sIgE-S-SA0.081,228Moderate
Morillo-Argudo DA ()2020EcuadorAmericaCross- sectional studyChildrenSR-SA1.941,338High
PD-SA0.751,338
SPT/sIgE-SA4.631,338
Ontiveros N ()2016MexicoAmericaCross- sectional studyChildrenSR-SA1.331,049Low
Rangkakulnuwat P ()2021ThailandAsiaCross- sectional studyChildrenSR-SA2.85561High
SPT/sIgE-S-SA1.45561
FC-SA0.58344
Warren CM ()2023USAAmericaCross- sectional studyChildrenSR-SA1.1938,408Moderate
AdultSR-SA2.9340,443
Zeng GQ ()2015ChinaAsiaCross- sectional studyChildrenPD-SA4.412,540Moderate
Woods RK ()2002AustraliaAustraliaCross- sectional studyAdultSPT/sIgE-SA2.541,141Moderate
SPT/sIgE-S-SA0.531,141
Caffarelli C ()2011ItalyEuropeCross- sectional studyChildrenPD-SA0.00625Low
Kjaer HF ()2008DenmarkEuropeBirth cohort studyChildrenSPT/sIgE-S-SA0.00351High
Kvenshagen B ()2009NorwayEuropeBirth cohort studyChildrenPD-SA0.00512Moderate
Le TM ()2015HollandEuropeCross- sectional studyAdultSR-SA0.933,864High
SPT/sIgE-S-SA0.701,430
FC-SA0.001,134
Kavaliunas A ()2012LithuaniaEuropeCross- sectional studyChildrenSR-SA0.103,084Low
SPT/sIgE-S-SA0.033,084
Mossakowska M ()2008PolandEuropeCross- sectional studyAdultSR-SA0.00301Low
Branum AM ()2009USAAmericaCross- sectional studyChildrenSPT/sIgE-SA5.203,712Low
Burney P ()2010MixedMixedCross- sectional studyAdultSPT/sIgE-SA5.404,220Low
Chen J ()2011ChinaAsiaCross- sectional studyChildrenSPT/sIgE-SA0.21477High
FC-SA0.00477
Eggesbo M ()1999NorwayEuropeBirth cohort studyChildrenSR-SA0.502,803Low
Hu Y ()2010ChinaAsiaCross- sectional studyChildrenSPT/sIgE-SA0.15686Moderate
Lao-araya M ()2012ThailandAsiaCross- sectional studyChildrenSR-SA3.36466High
SPT/sIgE-S-SA3.14466
FC-SA0.90466
Liu AH ()2010USAAmericaCross- sectional studyChildren-majoritySPT/sIgE-SA6.102,869High
AdultSPT/sIgE-SA5.794,425
Obeng BB ()2011GhanaAfricaCross- sectional studyChildrenSR-SA0.141,407High
Osterballe M ()2005DenmarkEuropecohort studyChildren-majorityFC-SA0.11898Moderate
AdultFC-SA0.32936
Osterballe M ()2009DenmarkEuropeCross- sectional studyAdult-majoritySR-SA2.02843Low
FC-SA1.34149
Rance F ()2005FranceEuropeCross- sectional studyChildrenSPT/sIgE-SA0.482,716Low
Santadusit S ()2005ThailandAsiaCross- sectional studyChildrenSR-SA1.22656Moderate
SPT/sIgE-S-SA0.75268
FC-SA0.75268
Wu TC ()2012TaiwanAsiaCross- sectional studyChildrenPD-SA3.8615,982Low
AdultPD-SA3.2714,036
Su KW ()2023TaiwanAsiaCross- sectional studyChildrenPD-SA4.256,510Moderate
AdultPD-SA6.129,690
Bedolla-Barajas M ()2015MexicoAmericaCross- sectional studyAdultSR-SA4.001,126Moderate
PD-SA3.821,126
Mejrhit N ()2019MoroccoAfricaCross- sectional studyChildrenSR-SA2.072,802Moderate
Domínguez-García MV ()2018AmericaAmericaCross- sectional studyAdultSR-SA2.751,200Low
PD-SA1.671,200
Gupta RS ()2018USAAmericaCross- sectional studyChildrenSR-SA1.0041,341Moderate
PD-SA0.5741,341
Feng H ()2022ChinaAsiaCross- sectional studyAdultSR-SA5.792,313Moderate
da S Correia JA ()2022BrazilAmericaCross- sectional studyChildrenSR-SA3.64412Low
Xiao S ()2023USAAmericaCross- sectional studyAdult-majoritySR-SA2.196,949Moderate
Trinh THK ()2024VietnamAsiaCross- sectional studyAdultSR-SA11.081,038Moderate

Summary of the characteristics of studies in the meta-analysis.

SR-SA, self-reported symptomatic allergy; PD-SA, self-reported physician-diagnosed allergy; SPT/sIgE-SA, SPT- or sIgE-based allergy; SPT/sIgE-S-SA, SPT- or sIgE-based symptomatic allergy; FC-SA, food challenge-confirmed allergy.

3.2 Prevalence of self-reported symptomatic SA

Among the included studies, 23 assessed SA using self-reported symptoms, with a total sample size of 167,835. The meta-analysis yielded a pooled prevalence of SA of 1.90% (95% CI: 1.44%–2.51%) (Figure 2A). Heterogeneity analysis indicated a high level of heterogeneity among the studies (I² = 97.67%, P < 0.05), suggesting considerable variability in prevalence estimates. Consequently, a random-effects model was applied for the meta-analysis.

Figure 2

Age-stratified analysis showed that the prevalence of self-reported symptomatic SA was 1.29% (95% CI: 0.97%–1.73%) in children, lower than that in adults (3.39%; 95% CI: 2.47%–4.64%). Region-specific analysis revealed prevalence rates of 3.75% (95% CI: 2.48%–5.64%) in Asia, 1.05% (95% CI: 0.62%–1.79%) in Europe, 1.95% (95% CI: 1.42%–2.68%) in America, and 1.06% (95% CI: 0.46%–2.42%) in Africa (Figure 2B).

Egger's regression test showed no evidence of publication bias (P = 0.92)); see Supplementary Figure S1 for the funnel plot.

3.3 Prevalence of self-reported physician-diagnosed SA

A total of 9 studies assessed SA based on self-reported physician diagnosis, with a combined sample size of 51,264. The meta-analysis yielded a pooled prevalence of 1.94% (95% CI: 1.10%–3.41%) (Figure 3A). The heterogeneity analysis indicated significant heterogeneity (I² = 99.21%, P < 0.05), necessitating the use of a random-effects model.

Figure 3

Age-stratified analysis revealed that the prevalence in children was 1.85% (95% CI: 1.04%–3.25%), lower than that in adults (3.03%; 95% CI: 1.68%–5.39%). Regional analysis showed prevalence rates of 3.39% (95% CI: 1.88%–6.76%) in Asia and 1.30% (95% CI: 0.62%–2.67%) in America (Figure 3B).

Egger's regression test showed no evidence of publication bias (P = 0.36); see Supplementary Figure S2 for the funnel plot.

3.4 Prevalence of SPT- or sIgE-based SA

Nine studies assessed SA based on SPT- or sIgE-testing, with a total sample size of 38,459. The pooled prevalence was 2.76% (95% CI: 1.91%–3.97%) (Figure 4A). Heterogeneity analysis revealed high variability (I² = 97.01%, P < 0.05), necessitating the use of a random-effects model.

Figure 4

Age-stratified analysis showed a prevalence of 2.61% (95% CI: 1.79%–3.81%) in children, lower than that in adults (4.42%; 95% CI: 2.69%–7.18%). Regional analysis revealed prevalence rates of 1.36% (95% CI: 0.65%–2.85%) in Asia and 5.23% (95% CI: 3.22%–8.40%) in America (Figure 4B).

Egger's regression test showed no evidence of publication bias (P = 0.29); see Supplementary Figure S3 for the funnel plot.

3.5 Prevalence of SPT- or sIgE-based symptomatic SA

Nine studies assessed SA using SPT- or sIgE-testing combined with symptoms, with a total sample size of 30,779. The pooled prevalence was 0.43% (95% CI: 0.24%–0.78%) (Figure 5A). Heterogeneity analysis showed moderate variability (I² = 62.86%, P < 0.05), necessitating the use of a random-effects model.

Figure 5

Age-stratified analysis revealed that the prevalence in children was 0.37% (95% CI: 0.15%–0.87%), slightly lower than that in adults (0.47%; 95% CI: 0.14%–1.52%). Regionally, the prevalence was 0.68% (95% CI: 0.25%–1.86%) in Asia and 0.18% (95% CI: 0.05%–0.56%) in Europe (Figure 5B).

Egger's regression test showed no evidence of publication bias (P = 0.71); see Supplementary Figure S4 for the funnel plot.

3.6 Prevalence of SA confirmed by food challenge

Seven studies assessed SA using food challenge testing, with a total sample size of 4,652. The meta-analysis yielded a pooled prevalence of 0.50% (95% CI: 0.30%–0.85%) (Figure 6A). Heterogeneity analysis indicated moderate variability (I² = 48.49%, P > 0.05), justifying the use of a fixed-effects model.

Figure 6

Age-stratified analysis showed that the prevalence in children was 0.59% (95% CI: 0.31%–1.14%), slightly higher than that in adults (0.45%; 95% CI: 0.19%–1.03%). Regional analysis indicated a prevalence of 0.68% (95% CI: 0.35%–1.33%) in Asia and 0.31% (95% CI: 0.13%–0.72%) in Europe (Figure 6B).

Egger's regression test showed no evidence of publication bias (P = 0.25); see Supplementary Figure S5 for the funnel plot.

4 Discussion

This meta-analysis systematically evaluated the global prevalence of SA by incorporating 40 studies from various regions and across different age groups. The pooled prevalence estimates were as follows: self-reported symptomatic SA 1.90%, self-reported physician-diagnosed SA 1.94%, SPT- or sIgE-based SA 2.76%, and SPT- or sIgE-based SA combined with clinical symptoms 0.43%, with a food challenge-confirmed SA of 0.50%. This highlights the risk of overestimation when relying solely on self-reported data.

A large cross-sectional study conducted by Helen T. Wang et al. during 2015–2016 at the National Opinion Research Center (NORC) at the University of Chicago assessed food allergy prevalence via telephone and online surveys. Their results indicated an overall crustacean allergy prevalence of 1.2% (95% CI: 1.0%–1.3%), which is highly consistent with the self-reported SA prevalence of 1.29% (95% CI: 0.97%–1.73%) observed among children in our study (). Moreover, our finding of a higher prevalence in adults compared to children aligns with trends observed in mollusk allergies, potentially due to cumulative sensitization with age. Similarly, a meta-analysis by Feng H et al. on the global prevalence of food allergies and associated factors reached the conclusion that adult mollusk allergy prevalence was higher than that in children (). Our study further confirmed significant regional variations in SA prevalence, suggesting an influence of dietary habits, genetic predisposition, and environmental factors (). Moonesinghe et al. published a systematic review in 2016 on the prevalence of shellfish allergy, which included studies published up to 2012 (). Our meta-analysis updates this by incorporating studies through 2025 and expanding coverage to underrepresented regions such as Asia, Africa, and South America. Moonesinghe's review reported self-reported SA prevalence ranging from 0.1%–5.5% in various populations, with clinically diagnosed prevalence in Taiwan at 3.3% for adults and up to 4.0% for children. Compared to previous estimates, our pooled results suggest that SA prevalence has slightly increased or remained stable in some high-income countries, while it may still be underestimated in several low- and middle-income countries due to limited data or study quality. Additionally, our refined subgroup analyses by diagnostic method and age provide a more comprehensive epidemiological overview.

In our analysis, most prevalence estimates exhibited considerable heterogeneity (I² > 90%), which may be attributed to several factors including geographic and cultural differences, racial and genetic factors, and methodological heterogeneity; for instance, shrimp consumption varies by region, so the higher prevalence observed in Asian regions might be related to the widespread consumption of shrimp and increased exposure to environmental risk factors, whereas lower prevalence rates in Europe and Africa could be due to differing dietary habits, and in coastal areas where seafood consumption is higher, the prevalence of SA may also be elevated, although there is currently a lack of direct literature evidence to support these hypotheses; additionally, variations in genetic susceptibility among different ethnic groups may influence the development of allergies, while differences in sample sizes, study designs (e.g., cross-sectional vs. cohort studies), and data collection methods (e.g., questionnaire surveys vs. clinical testing) across studies may affect comparability and further contribute to the observed heterogeneity. Moreover, the use of varied diagnostic methods—ranging from self-reports to oral food challenges—has introduced further heterogeneity. To better account for this, we categorized the included studies into five diagnostic groups: 1. self-reported symptomatic SA, 2. self-reported physician-diagnosed SA, 3. positive SPT or sIgE SA, 4. probable SA (defined as sensitization plus clinical symptoms), and 5. food challenge-confirmed SA. This classification reflects the current heterogeneity in the literature and enabled structured subgroup analyses in our meta-analysis.

While self-reported SA is widely used in large-scale epidemiological studies due to its convenience, it often overestimates prevalence owing to poor specificity. In contrast, SPT and sIgE indicate sensitization, but not necessarily clinical allergy. The “probable SA” category attempts to bridge this gap and may better reflect true disease burden. Oral food challenge, although the gold standard, is rarely feasible in large-scale studies due to cost, time, and ethical constraints. These diagnostic methods are widely used across existing studies, and almost all prevalence research on SA has employed one or more of these definitions. Thus, adopting this classification scheme provided a practical and comprehensive framework for synthesis.

Understanding SA prevalence is crucial for risk assessment and public health strategies. The discrepancy between self-reported and confirmed allergy prevalence suggests a need for improved diagnostic accuracy in clinical practice. Public health strategies should focus on: Increasing awareness of SA and proper diagnostic methods. Implementing educational programs to prevent unnecessary dietary restrictions. Ensuring access to epinephrine auto-injectors in high-risk populations.

While we followed the PRISMA guidelines closely and employed a comprehensive search strategy encompassing diverse populations, several limitations remain. First, the considerable heterogeneity among studies limits the broad applicability of the pooled prevalence estimates. Second, the paucity of studies from certain regions, particularly in Europe and Africa, may restrict the global generalizability of our findings. Third, differences in the methodological quality of the included studies could affect the reliability of the data and, consequently, the accuracy of the pooled estimates. To address this concern, we categorized studies based on methodological quality and conducted subgroup analyses accordingly. However, the differences in prevalence estimates between high- and lower-quality studies were minimal. Fourth, the failure to differentiate between IgE-mediated and non-IgE-mediated food allergies, as well as food intolerances, might result in an overestimation of the prevalence of IgE-mediated SA. In the studies included in our meta-analysis, the reporting of this information was inconsistent. A substantial number of studies did not specify whether the reported shellfish allergy was IgE-mediated, which limited our ability to conduct stratified analyses. Fifth, to estimate the true prevalence of SA, we adjusted for participant dropout in some studies based on the proportion of individuals who completed the study. However, this proportional adjustment may not fully reflect reality; for example, individuals with severe allergies are more likely to decline participation in oral food challenge (OFC) tests, leading to their underrepresentation in the study samples and potentially biasing the pooled prevalence estimates.

To further enhance our understanding of SA prevalence and its determinants, future research should focus on prospective cohort studies to follow the natural history of SA from childhood into adulthood. Additionally, developing standardized diagnostic criteria is essential to improve comparability across studies and reduce heterogeneity. In high-prevalence regions, further investigation into the genetic and environmental factors contributing to SA is warranted, along with assessments of the impact on quality of life, economic burden, and healthcare resource use. Such efforts will yield a more robust evidence base for public health policies and clinical strategies.

This meta-analysis provides the most comprehensive synthesis to date on the global prevalence of SA, revealing substantial variations by age and region. This underscores the need for standardized diagnostic criteria to improve study comparability and diagnostic accuracy. Future research should focus on optimizing diagnostic protocols and identifying risk factors contributing to SA prevalence.

Statements

Data availability statement

Publicly available datasets were analyzed in this study. This data can be found here: All data analyzed in this study were obtained from publicly available sources, including published literature from PubMed, Web of Science, and Embase. The dataset supporting the findings of this study is available from the corresponding author upon reasonable request.

Author contributions

JC: Data curation, Conceptualization, Writing – original draft. QZ: Writing – original draft, Methodology, Investigation, Data curation. YY: Investigation, Writing – original draft. XZ: Data curation, Investigation, Writing – original draft. CQ: Supervision, Writing – review & editing, Funding acquisition.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Science and Technology Plan Project of Lishui (2022SJZC033) and the Basic Public Welfare Research Program of Zhejiang Province (LGC22H100002).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/falgy.2025.1635274/full#supplementary-material

References

Summary

Keywords

shrimp allergy, prevalence, sensitization, meta-analysis, food allergy epidemiology

Citation

Chen J, Zhang Q, Ying Y, Zhang X and Qu C (2025) Prevalence of shrimp allergy: a meta-analysis based on different diagnostic methods. Front. Allergy 6:1635274. doi: 10.3389/falgy.2025.1635274

Received

02 June 2025

Accepted

08 August 2025

Published

01 September 2025

Volume

6 - 2025

Edited by

Jonathan S. Tam, Children's Hospital of Los Angeles, United States

Reviewed by

Roni Nugraha, IPB University, Indonesia; Fifa Argentina, Sriwijaya University, Indonesia

Updates

Copyright

*Correspondence: Chunsheng Qu

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics